logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
B

Benjamin Y. Kong

nelune comprehensive cancer centre
H指数:18
被引数:3,234

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplifications: a molecular screening and therapeutics (MoST) program substudy

Tucatinib和曲妥珠单抗在HER2突变或扩增的晚期癌症中的研究：分子筛查和治疗（MoST）计划子研究

npj Precision Oncology
IF8
2026-07-240
OA
Benjamin Y. Kong; Frank Po-Yen Lin; David Espinoza; Mason Aberoumand; Subotheni Thavaneswaran; Tarek Meniawy; Jayesh Desai; Rosemary Harrup; Sudarshan Selva Nayagam; Michail Charakidis; Katharine Cuff; Lucille Sebastian; Chee Khoon Lee; Patrick Wheeler; Maya Kansara; John P. Grady; David M. Thomas; Mandy L. Ballinger; John Simes; David Goldstein
Real-world treatment sequencing and survival in ROS1-Rearranged NSCLC across evolving treatment eras: Findings from the AURORA multi-centre registry (AURORA-ROS1)

ROS1重排非小细胞肺癌在演变的治疗时代中的真实世界治疗序列与生存情况：AURORA多中心登记研究（AURORA-ROS1）的结果

Lung Cancer
IF4.4
2026-06-170
PRE
Malinda Itchins; Marliese Alexander; Steven Kao; Adnan Nagrial; Lauren J. Brown; Samantha Bowyer; Sagun Parakh; Melissa Moore; Benjamin Y. Kong; Nicholas Yeo; Brett G.M. Hughes; Surein Arulananda; Venessa Chin; Lydia Warburton; Trisha Khoo; Antony J. Mersiades; Lilian Leigh; Jennifer Rogers; Nick Pavlakis; Benjamin J. Solomon
Impact of PD-L1 on first-line osimertinib outcomes in EGFR-mutant NSCLC: real-world data from the AURORA25 study and meta-analysis

PD-L1对EGFR突变型NSCLC一线奥希替尼疗效的影响：AURORA25研究真实世界数据与荟萃分析

Lung Cancer
IF4.4
2025-11-240
PRE
Marliese Alexander; Malinda Itchins; Jonathan Felthun; Adnan Nagrial; Lauren J. Brown; Kenneth O’Byrne; Antony J. Mersiades; Brett G.M. Hughes; Lydia Warburton; Benjamin Y. Kong; Melissa Moore; Prunella Blinman; Samantha Bowyer; Timothy Clay; Tim Spelman; Benjamin J. Solomon; Steven Kao
PATH-18. Investigating the role of CDKN2A loss in IDH-mutant gliomas: biological insights beyond tumour grading

PATH-18. 研究CDKN2A缺失在IDH突变型胶质瘤中的作用：超越肿瘤分级的生物学见解

Neuro-Oncology
IF13.4
2025-11-110
OA
Alexander Yuile; Laveniya Satgunaseelan; Kimberly L Alexander; Subotheni Thavaneswaran; Hao-Wen Sim; Ashraf Zaman; Joseph Powell; Aijia Meng; Cecile Escher; Joe Q Wei; Grace Wei; Maggie Lee; Michael E Buckland; Benjamin Y Kong; Marina Kastelan; Mark Wong; Isabella Wilson; Angela Bayly; Winny Varikatt; Zarnie Lwin; Michael Rodriguez; Hwei Choo Soh; Anthony Gill; Razia Zakarya; Michael F Back; Nick Pavlakis; David L Chan; Adrian Lee; Helen R Wheeler; Amanda L Hudson
Tucatinib and trastuzumab in advanced cancers with HER2 mutations or amplification: A molecular screening and therapeutics (MoST) program substudy

Tucatinib和Trastuzumab在HER2突变或扩增的晚期癌症中的应用：一项分子筛查与治疗（MoST）计划亚研究

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Kong, B. Y.; Lin, F. P-Y.; Espinoza, D.; Thavaneswaran, S.; Meniawy, T.; Desai, J.; Harrup, R.; Selva-Nayagam, S.; Charakidis, M.; Cuff, K.; Sebastian, L.; Lee, C. K.; Chinchen, S.; Thomas, D. M.; Ballinger, M. L.; Simes, J.; Goldstein, D.
First-line chemoimmunotherapy and immunotherapy in patients with non-small cell lung cancer and brain metastases: a registry study
FRONTIERS IN ONCOLOGY
IF3.3
2024-02-074
OAAI
Brown, Lauren Julia; Khou, Victor; Brown, Chris; Alexander, Marliese; Jayamanne, Dasantha; Wei, Joe; Gray, Lauren; Chan, Wei Yen; Smith, Samuel; Harden, Susan; Mersiades, Antony; Warburton, Lydia; Itchins, Malinda; Lee, Jenny H.; Pavlakis, Nick; Clarke, Stephen J.; Boyer, Michael; Nagrial, Adnan; Hau, Eric; da Silva, Ines Pires; Kao, Steven; Kong, Benjamin Y.
NUTMEG: A randomized phase II study of nivolumab and temozolomide versus temozolomide alone in newly diagnosed older patients with glioblastoma

肉豆蔻: nivolumab和替莫唑胺与替莫唑胺单独治疗新诊断的老年胶质母细胞瘤患者的随机II期研究

NEURO-ONCOLOGY ADVANCES
IF4.1
2023-09-227
OAAI
Sim, Hao-Wen; Wachsmuth, Luke; Barnes, Elizabeth H.; Yip, Sonia; Koh, Eng-Siew; Hall, Merryn; Jennens, Ross; Ashley, David M.; Verhaak, Roel G.; Heimberger, Amy B.; Rosenthal, Mark A.; Hovey, Elizabeth J.; Ellingson, Benjamin M.; Tognela, Annette; Gan, Hui K.; Wheeler, Helen; Back, Michael; Mcdonald, Kerrie L.; Long, Anne; Cuff, Katharine; Begbie, Stephen; Gedye, Craig; Mislang, Anna; Le, Hien; Johnson, Margaret O.; Kong, Benjamin Y.; Simes, John R.; Lwin, Zarnie; Khasraw, Mustafa
Anti-PD-1 Monoclonal Antibodies (mAbs) Are Superior to Anti-PD-L1 mAbs When Combined with Chemotherapy in First-Line Treatment for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Network Meta-Analysis

Anti-PD-1单克隆抗体 (mab) 联合化疗一线治疗转移性非小细胞肺癌 (mNSCLC) 优于Anti-PD-L1单克隆抗体: 一项网状Meta分析

BIOMEDICINES
IF3.9
2023-06-262
OAAI
Wei, Joe Q. Q.; Yuile, Alexander; Itchins, Malinda; Kong, Benjamin Y. Y.; Li, Bob T. T.; Pavlakis, Nick; Chan, David L. L.; Clarke, Stephen J. J.
BRAF-mediated brain tumors in adults and children: A review and the Australian and New Zealand experience
FRONTIERS IN ONCOLOGY
IF3.3
2023-04-145
OAAI
Trinder, Sarah M.; McKay, Campbell; Power, Phoebe; Topp, Monique; Chan, Bosco; Valvi, Santosh; McCowage, Geoffrey; Govender, Dinisha; Kirby, Maria; Ziegler, David S.; Manoharan, Neevika; Hassall, Tim; Kellie, Stewart; Heath, John; Alvaro, Frank; Wood, Paul; Laughton, Stephen; Tsui, Karen; Dodgshun, Andrew; Eisenstat, David D.; Endersby, Raelene; Luen, Stephen J.; Koh, Eng-Siew; Sim, Hao-Wen; Kong, Benjamin; Gottardo, Nicholas G.; Whittle, James R.; Khuong-Quang, Dong-Anh; Hansford, Jordan R.
Distinguishing human peripheral blood CD16+ myeloid cells based on phenotypic characteristics
JOURNAL OF LEUKOCYTE BIOLOGY
IF3.1
2019-11-2110
OAAI
Fromm, Phillip D.; Silveira, Pablo A.; Hsu, Jennifer L.; Papadimitrious, Michael S.; Lo, Tsun-Ho; Ju, Xinsheng; Kupresanin, Fiona; Romano, Adelina; Hsu, Wei-Hsun; Bryant, Christian E.; Kong, Benjamin; Abadir, Edward; Mekkawy, Ahmed; McGuire, Helen M.; de St Groth, Barbara Fazekas; Cunningham, Ilona; Newman, Elizabeth; Gibson, John; Hogarth, P. Mark; Hart, Derek N. J.; Clark, Georgina J.
Implementation of Standardized Clinical Processes for TPMT Testing in a Diverse Multidisciplinary Population: Challenges and Lessons Learned
CTS-CLINICAL AND TRANSLATIONAL SCIENCE
IF2.8
2018-01-1928
OAAI
Weitzel, Kristin W.; Smith, D. Max; Elsey, Amanda R.; Duong, Benjamin Q.; Burkley, Benjamin; Clare-Salzler, Michael; Gong, Yan; Higgins, Tara A.; Kong, Benjamin; Langaee, Taimour; McDonough, Caitrin W.; Staley, Benjamin J.; Vo, Teresa T.; Wake, Dyson T.; Cavallari, Larisa H.; Johnson, Julie A.
Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy

先前anti-PD-1治疗后转移性黑色素瘤患者使用anti-CTLA-4抗体ipilimumab治疗的疗效和毒性

BRITISH JOURNAL OF CANCER
IF6.8
2016-04-28109
OAAI
Bowyer, S.; Prithviraj, P.; Lorigan, P.; Larkin, J.; McArthur, G.; Atkinson, V.; Millward, M.; Khou, M.; Diem, S.; Ramanujam, S.; Kong, B.; Liniker, E.; Guminski, A.; Parente, P.; Andrews, M. C.; Parakh, S.; Cebon, J.; Long, G. V.; Carlino, M. S.; Klein, O.

研究方向

暂未获取到该数据
M
Matteo S. Carlino
H 指数:82论文数:667被引数:5.7万
G
Georgina V. Long
H 指数:169论文数:1,834被引数:17.4万
R
Richard Kefford
H 指数:125论文数:613被引数:10.3万
E
Elizabeth Liniker
H 指数:12论文数:69被引数:1,823
S
Sangeetha Ramanujam
H 指数:7论文数:24被引数:1,299
A
Alexander M. Menzies
H 指数:85论文数:760被引数:3.1万
M
Marliese Alexander
H 指数:21论文数:156被引数:1,441
A
Alexander Guminski
H 指数:45论文数:243被引数:1.3万
P
Phillip D. Fromm
H 指数:20论文数:61被引数:1,366
H
Hao‐Wen Sim
H 指数:19论文数:155被引数:1,563